Added to YB: 2019-09-11
Pitch date: 2019-09-11
BCYC:US [bullish]
Bicycle Therapeutics plc
-23.75%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.
Market Cap
$449.5M
Pitch Price
$9.77
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.70
P/E
-1.79
EV/Sales
-6.81
Sector
Biotechnology
Category
N/A
Show full summary:
BICYCLE THERAPEUTICS PLC SPONS ADR BCYC:US
A summary for this pitch has not been created yet.
Read full article (0 min)